McKesson stock snapshot and recent performance McKesson (MCK) has drawn investor attention recently as its share price sits ...
Zacks Investment Research on MSN
McKesson builds earnings momentum on specialty and automation
McKesson Corporation MCK has delivered a strong fiscal second quarter, reinforcing confidence in management’s full-year ...
McKesson Corporation (NYSE:MCK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 10, Deutsche ...
Healthcare giant McKesson Corp. on Tuesday said it will spin off its Technology Solutions unit and merge it with revenue cycle company Change Healthcare, creating a yet-to-be named healthcare services ...
Healthcare services company McKesson has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures (Core Ventures) for about $2.49 ...
Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By ...
McKesson declined about 20% in the last few weeks and sentiment suddenly turned. Of course, McKesson is performing hand-in-hand with the overall market and we can expect that McKesson will continue to ...
McKesson has entered into a definitive agreement to acquire CoverMyMeds, a developer of electronic prior authorization technology, for $1.1 billion or $0.9 billion net of cash incremental cash ...
Deal Rationale McKesson’s strategic focus on disciplined portfolio management involves continuous evaluation of its business segments to ensure alignment with its growth priorities and optimize ...
In October, we joined forces with the Washington Post and reported a disturbing story of Washington at its worst - about an act of Congress that crippled the DEA's ability to fight the worst drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results